anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Source Note

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,355
Current window 46,411-46,440
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all
18 30 60

Component

46,411-46,440 of 110,355

filter-aware
274
The slide presents qualitative expert testimony regarding drug discontinuation rates.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
275
The slide uses direct quotes from a consultation call to challenge the drug's safety and efficacy profile.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
276
The slide contrasts the prescriber's relaxed attitude toward cardiac/hepatic monitoring with a specific, concerning anecdote about a patient experiencing uncontrollable anger.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
277
The slide uses a Q&A format to validate the prescriber's credentials and patient volume.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
278
The slide uses a Q&A format to present qualitative feedback from a specific physician.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
279
The slide highlights key negative sentiment regarding market saturation and physician adoption hurdles.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
280
The slide highlights potential regulatory/compliance risks (lack of monitoring) and commercial opacity (pricing) regarding the drug Wakix.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
281
The slide presents a transcript of an interview with a physician, highlighting negative clinical experience.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
282
The slide uses bolding and highlighting to emphasize negative sentiment from a key opinion leader.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
283
The slide uses a Q&A format to highlight a specific adverse event and the resulting loss of confidence in the drug's safety profile.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
284
The slide uses a Q&A format to document a specific adverse event case study.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
285
The slide uses a Q&A transcript format to detail a specific medical case study involving drug safety concerns.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
286
The slide highlights a potential safety concern and a perceived lack of transparency or concern from the manufacturer's sales representative.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
287
The slide uses a Q&A format to provide evidence for the summary points listed in the title.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
289
The slide uses a Wikipedia table to explain DEA drug schedules to frame the competitive landscape.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
290
The slide uses direct quotes from KOLs and specialists to undermine a specific company value proposition.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
291
The slide uses a Q&A format to provide expert validation that scheduling is not a significant barrier to prescription.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
292
The slide uses direct quotes to expose a contradiction between the company's marketing (non-controlled status) and the actual physician experience (high administrative burden).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
293
The slide uses highlighted text to emphasize key negative sentiments from expert interviews.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
295
The slide uses a screenshot of the Wakix website to highlight the specific claim being challenged.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
296
The slide uses screenshots of two different websites to demonstrate consistent messaging across patient and HCP channels.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
297
The slide uses a 'preempt_rebuttal' or 'expose_contradiction' style to challenge the scientific validity of a drug's mechanism of action claims.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
298
The slide uses a 'fraud-exposure' approach by highlighting circular citations and methodological weaknesses in the foundational research.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
299
The slide uses scientific data to challenge the validity of the drug's efficacy claims by highlighting the high dosage required in animal models.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
301
The slide uses a specific academic paper to undermine the scientific premise of a drug's mechanism of action.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
302
The slide uses box-whisker plots to demonstrate a lack of correlation between histamine/metabolite levels and various sleep disorder etiologies.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
303
The slide uses a direct excerpt from a scientific paper to undermine a previous scientific claim.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
304
The slide uses a direct quote from a scientific editorial to discredit a previously held hypothesis regarding pitolisant's mechanism of action.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
305
The slide uses underlined text to emphasize key findings that contradict the company's narrative.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
307
The slide uses a combination of narrative argument and direct excerpts from regulatory documents to highlight a discrepancy in drug efficacy claims.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit